Lipricain

Lidocaine, the active ingredient in Lipricain, is a local anesthetic presented as a topical formulation for cutaneous use. It provides surface numbness to reduce pain during minor skin procedures and other superficial discomforts. Lidocaine works together with prilocaine, another amide‑type anesthetic, to enhance the depth and duration of local anesthesia.

GNH USA supplies Lipricain as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lipricain, a combination of lidocaine and prilocaine, is used for topical anesthesia in the following situations: - Minor skin surgery: provides local numbing to facilitate painless incision and suturing. - Dermal procedures (e.g., laser therapy, biopsies): reduces procedural discomfort on the skin surface. - Minor burns and superficial injuries: alleviates pain and burning sensation. - Insect bites or minor abrasions: offers temporary relief from itching and pain. - Cosmetic dermatology (e.g., microdermabrasion): improves patient comfort during treatment.

Topical application of Lipricain may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Burning or stinging at the application site. - Redness or erythema of the skin. - Localized swelling or edema. - Itching or pruritus. - Mild skin irritation or rash.

Serious or Rare Side Effects: - Methemoglobinemia, especially with extensive use. - Systemic toxicity presenting as dizziness, seizures, or cardiac arrhythmia. - Severe allergic reactions, including contact dermatitis or anaphylaxis. - Persistent numbness beyond the intended area. - Tissue necrosis if applied to compromised skin.

When using Lipricain, consider the following safety measures: - Allergy assessment: avoid use in patients with known hypersensitivity to amide local anesthetics. - Skin integrity: apply only to intact, non‑inflamed skin; do not use on open wounds or mucous membranes. - Surface area limitation: restrict application to the recommended area to prevent systemic absorption. - Concurrent anesthetics: do not combine with other topical or injectable local anesthetics without medical supervision. - Monitoring: observe for signs of systemic toxicity, especially in pediatric or elderly patients. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Lipricain may interact with other drugs that affect cardiac conduction or metabolism.

Major Interactions (Avoid): - Other amide‑type local anesthetics: additive risk of systemic toxicity. - Class I antiarrhythmic agents (e.g., quinidine, procainamide): may exacerbate cardiac conduction disturbances.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., erythromycin, ketoconazole): can increase plasma levels of lidocaine. - Beta‑blockers: may mask early signs of local anesthetic toxicity. - Alcohol or CNS depressants: enhance central nervous system depression. - Certain antihistamines: may potentiate allergic skin reactions.